A2ML1 Inhibits Esophageal Squamous Cell Carcinoma Progression and Serves as a Novel Prognostic Biomarker

Figure 3

A2ML1 overexpression suppressed ESCC growth in vivo. (a) Subcutaneous tumor growth was monitored weekly after ESCC cell injection according to the tumor volume. (b) Four weeks after the tumor cell injection, the tumor nodes were isolated and weighed to compare their differences; , Student’s t-test. (c) Representative images of tumor nodes; , Student’s t-test. (d) Representative images of Ki67 protein expression in the vector and A2ML1 overexpression groups. (e) IHC staining for Ki67 in mouse tumor tissue from the vector and overexpression groups and scatter plot for Ki67 expression; , Student’s t-test.

(a)

(b)

(c)

(d)

(e)